Celcuity Inc. (CELC) Financials

CELC Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 410.2 million 356.6 million
Dec. 31, 2025 466.6 million 366.0 million
Sept. 30, 2025 476.0 million 359.0 million
June 30, 2025 183.6 million 139.2 million

CELC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -55.3 million 5.3 million
Dec. 31, 2025 -36.5 million 9.5 million
Sept. 30, 2025 -44.9 million 6.8 million
June 30, 2025 -36.3 million 2.7 million

CELC Net Income

No data available :(

CELC Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 145.2 million 195.6 million 13000
Dec. 31, 2025 441.5 million 195.3 million 54000
Sept. 30, 2025 455.0 million 320.2 million 96000
June 30, 2025 168.4 million 99.3 million 139000

CELC Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 54.5 million
Dec. 31, 2025 52.5 million
Sept. 30, 2025 44.8 million
June 30, 2025 43.7 million

CELC Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 249000 33.1 million 17.4 million -
Dec. 31, 2025 53000 37.6 million 11.6 million -
Sept. 30, 2025 97000 34.9 million 7.9 million -
June 30, 2025 39000 40.2 million 3.8 million -

CELC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 47000
Dec. 31, 2025 - -
Sept. 30, 2025 154000 41000
June 30, 2025 - 40000

CELC

Price: $88.24

52 week price:
11.28
151.02

Earnings Per Share: -3.90 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 28600

Market Capitalization: 4.3 billion

Links: